论文信息 - Failure of systemic propranolol therapy for choroidal hemangioma of Sturge-Weber syndrome: a report of 2 cases.

Failure of systemic propranolol therapy for choroidal hemangioma of Sturge-Weber syndrome: a report of 2 cases.

Propranolol was incidentally discovered to induce accelerated involution of infantile cutaneous hemangioma. Thereafter, reports have demonstrated a favorable response to propranolol as a first-line treatment for cutaneous, orbital, and ocular hemangioma in different ages. We report the outcome of oral propranolol therapy in 2 cases with choroidal hemangioma of SturgeWeber syndrome (SWS).

H. Krema | P. Durairaj | Y. Yousef | Ronaldo Santiago

[1] J. Arevalo,et al. Oral propranolol for exudative retinal detachment in diffuse choroidal hemangioma. , 2011, Archives of ophthalmology.

[2] E. A. Greene,et al. Status of Propranolol for Treatment of Infantile Hemangioma and Description of a Randomized Clinical Trial , 2011, The Annals of otology, rhinology, and laryngology.

[3] A. Zvulunov,et al. Oral Propranolol Therapy for Infantile Hemangiomas Beyond the Proliferation Phase: A Multicenter Retrospective Study , 2011, Pediatric dermatology.

[4] P. Hoeger,et al. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action , 2010, The British journal of dermatology.

[5] F. Boralevi,et al. Propranolol for severe hemangiomas of infancy. , 2008, The New England journal of medicine.

[6] R. L. Font,et al. Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of the literature. , 1976, Survey of ophthalmology.